When sourcing electronic components for medical device applications, understanding FDA certification requirements is critical for both buyers and suppliers. The regulatory landscape underwent significant changes in 2026, with the FDA's Quality Management System Regulation (QMSR) becoming effective on February 2, 2026. This new regulation integrates ISO 13485:2016 into the US medical device quality framework, replacing the previous Quality System Regulation (QSR) [1].
For electronic component suppliers like those manufacturing super capacitors, the key question is: Do you need FDA certification to sell medical grade products? The answer is nuanced. Component manufacturers are not directly regulated by FDA in the same way as finished medical device manufacturers. However, medical device OEMs who purchase your components are required to maintain supplier control processes under the QMSR framework. This means they will demand documentation, quality certifications, and traceability from their component suppliers.
The distinction between FDA registration and FDA certification is important. FDA does not issue 'certifications' for components. Instead, medical device manufacturers register their facilities and list their products with FDA. Component suppliers support this process by providing documentation such as material certificates, test reports, and quality management system certifications (ISO 13485 or ISO 9001). For Southeast Asian exporters looking to sell on Alibaba.com, understanding this distinction helps position products appropriately for medical device procurement.
FDA adopted ISO 13485:2016 on February 2, 2026. The Quality Management System Regulation (QMSR) now requires medical device manufacturers to establish comprehensive quality systems. Component suppliers must follow customer-specific requirements for design control, supplier management, and traceability. While component certification is not mandatory, many medical device customers require ISO 13485 certification from their suppliers [1].

